- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:58 | Clock starts ticking on UK's single patient record plan | ||
| 12:58 | Readout for AZ's hypoparathyroidism drug raises questions | ||
| 11:58 | Novo, Lilly trade oral GLP-1 data readouts at ECO | ||
| Di | Reports: Makary out, Diamantas in as FDA commissioner | ||
| Di | Isomorphic raises $2.1bn for AI drug hunt | ||
| Di | Boehringer, Brainomix plan new trial of lung fibrosis AI | ||
| Di | EU agrees plan to tackle essential medicine shortages | ||
| Di | Novo says high-dose Wegovy can cause 28% weight loss | ||
| Di | BMS signs $15.2bn R&D alliance with China's Hengrui | ||
| Di | Cellular Intelligence scoops up Novo's Parkinson's therapy | ||
| Mo | Novo Nordisk microRNA drug fluffs its lines in heart failure | ||
| Mo | GSK enlists local aid for Chinese rollout of hep B drug | ||
| Mo | Deal finally unlocks NHS access to ITF's Duchenne drug | ||
| Mo | Partner's Bizengri is first drug for rare, aggressive cancer | ||
| Mo | Is Makary on the way out, and who might replace him? | ||
| Fr | Capricor sues partner Nippon Shinyaku in DMD therapy spat | ||
| Fr | Eisai, Biogen face delay to subcutaneous Leqembi | ||
| Fr | J&J seeks to rewrite the script on depression treatment | ||
| Fr | Windward raises $165m for TSLP drug, and other biofinancings | ||
| Fr | Manufacturing hangover drives Daiichi Sankyo into the red | ||
| Do | Bayer plans filings for cardiac amyloidosis imaging agent | ||
| Do | Roche buys AI-powered diagnostics player PathAI | ||
| Do | Mike Guarino appointed to lead EVERSANA INTOUCH | ||
| Do | Angelini seeks US beachhead with $4.1bn Catalyst buy | ||
| 06.05. | Lilly inflates US facility investment spending by $4.5bn |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.